Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Orilyse Fast
- Development stage
- Unknown
- Lead developer
- IBSA
- Administration
- Otic
01
Overview
Orilyse Fast is an ear spray formulated with 100% isotonic seawater, designed for daily ear hygiene and the mechanical removal of excess earwax and accumulated fluids in the external auditory canal. Developed by IBSA Pharma (formerly Laboratoires Genévrier), it is classified as a Class IIa medical device in Europe. The isotonic seawater solution helps dissolve and eliminate earwax buildup gently and painlessly, preventing the formation of earwax plugs and reducing the risk of hearing problems associated with fluid stagnation. It features an 'Easy Spray' dispensing mechanism that allows for 360-degree application.
- Brand names
- Orilyse Fast
- Other names
- Orilyse Fast Sea Water Ear SprayOrilyse Fast spray auriculaire
Beyond the preview
Go deeper on Orilyse Fast.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Orilyse Fast.